Unibest
← Back to patent-cliff list

CAS 503309-11-3

[2-Fluoro-4-(trifluoromethyl)phenyl]boronic acid

Codes: (VII)1078735-1-a, (X)1078735-2-a, (V)1078735-3-a, (III)1078735-4-a

Application context (from source-drug indications)

Breast cancerImlunestrant TosylateMetastatic breast cancerImlunestrant TosylateMetastatic cancerImlunestrant TosylateOvarian cancerImlunestrant TosylateEndometrial cancerImlunestrant TosylateColorectal cancerImlunestrant Tosylate

Source drugs (routes using this intermediate)

DrugTierExpiry
Imlunestrant TosylateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Imlunestrant TosylateOptimised routesteps: 8total yield: /
4-Hydroxy-7-methoxyquinoline→3-Chloro-4-hydroxy-7-methoxyquinoline→4-Bromo-3-chloro-7-methoxyquinoline→(4-Fluorophenyl)methanone→(3-Chloro-7-methoxyquinolin-4-yl)(4-fluorophenyl)methanone→4-Fluoranylbenzoyl chloride→(3-Chloro-7-hydroxyquinolin-4-yl)(4-fluorophenyl)methanone→1,1-Diethoxy-2-hydroxyethane→(3-Chloro-7-hydroxyquinolin-4-yl)[4-(2,2-diethoxyethoxy)phenyl]methanone→[2-Fluoro-4-(trifluoromethyl)phenyl]boronic acid→[4-(2,2-Diethoxyethoxy)phenyl][3-[2-fluoro-4-(trifluoromethyl)phenyl]-7-hydroxyquinolin-4-yl]methanone→(4-Fluorophenyl)[3-[2-fluoro-4-(trifluoromethyl)phenyl]-7-hydroxyquinolin-4-yl]methanone→4-[(R)-[4-(2,2-Diethoxyethoxy)phenyl](hydroxy)methyl]-3-[2-fluoro-4-(trifluoromethyl)phenyl]quinolin-7-ol→(5R)-5-[4-(2,2-Diethoxyethoxy)phenyl]-8-(trifluoromethyl)-5H-[1]benzopyrano[4,3-c]quinolin-2-ol
Imlunestrant TosylateOptimised routesteps: 6total yield: /
4-Bromo-3-chloro-7-methoxyquinoline→4-Fluoro-2,3,5,6-tetradeutero-benzoyl chloride→(3-Chloro-7-methoxyquinolin-4-yl)[4-fluoro-2,3,5,6-tetradeutero-phenyl]methanone→(3-Chloro-7-hydroxyquinolin-4-yl)[4-fluoro-2,3,5,6-tetradeutero-phenyl]methanone→[2-Fluoro-4-(trifluoromethyl)phenyl]boronic acid→[4-Fluoro-2,3,5,6-tetradeutero-phenyl][3-[2-fluoro-4-(trifluoromethyl)phenyl]-7-hydroxyquinolin-4-yl]methanone→2-[3-(Fluoromethyl)azetidin-1-yl]ethan-1-ol→[4-[2-[3-(Fluoromethyl)azetidin-1-yl]ethoxy]-2,3,5,6-tetradeutero-phenyl][3-[2-fluoro-4-(trifluoromethyl)phenyl]-7-hydroxyquinolin-4-yl]methanone→4-[[4-[2-[3-(Fluoromethyl)azetidin-1-yl]ethoxy]-2,3,5,6-tetradeutero-phenyl](hydroxy)methyl]-3-[2-fluoro-4-(trifluoromethyl)phenyl]quinolin-7-ol→(±)-5-[4-[2-[3-(Fluoromethyl)azetidin-1-yl]ethoxy]-2,3,5,6-tetradeutero-phenyl]-8-(trifluoromethyl)-5H-[1]benzopyrano[4,3-c]quinolin-2-ol
Imlunestrant TosylateOptimised routesteps: 2total yield: /
4-Hydroxy-7-methoxyquinoline-3-carboxylic acid→3-Iodo-7-methoxyquinolin-4-ol→[2-Fluoro-4-(trifluoromethyl)phenyl]boronic acid→3-[2-Fluoro-4-(trifluoromethyl)phenyl]-7-methoxyquinolin-4-ol

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.